MISSISSAUGA, ON, March 11, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its financial and operating results for the three and twelve months ended December 31, 2021 after market close on March 17, 2022. The Company will also host a conference call on Friday, March 18, 2022 at 8:30am ET to discuss the results and corporate developments.  

CONFERENCE CALL DETAILS

DATE: March 18, 2022

TIME: 8:30 a.m. ET

DIAL-IN NUMBER: (647) 794-4605 or (888) 204-4368

CONFERENCE ID: 1673781

REPLAY DIAL-IN: (888) 203-1112 (playback 1673781#)

       Expires March 25, 2022

WEBCAST: https://produceredition.webcasts.com/starthere.jsp?ei=1533942&tp_key=62d3cb0b34

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

 

SOURCE Cipher Pharmaceuticals Inc.

Copyright 2022 Canada NewsWire

Cipher Pharmaceuticals (TSX:CPH)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Cipher Pharmaceuticals Charts.
Cipher Pharmaceuticals (TSX:CPH)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Cipher Pharmaceuticals Charts.